Previous studies using IHC and a Western blot have demonstrated elevated Beclin 1 and LC3 expression in advanced ovarian cancer tissue samples, whereas our study utilized ELISA on ascitic fluid [17]. The gene discussed is MAP1LC3A; the disease is ovarian carcinoma.